22157.jpg
ZONTIVITY Market Size, Forecast and Market Insight 2024-2032 - ZONTIVITY Emerges as a Promising Therapeutic for Peripheral Artery Disease
April 02, 2024 07:11 ET | Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "ZONTIVITY Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
22157.jpg
Aspirin Global Market Report 2024: Robust Growth Projected with Rising Arthritis and Cardiovascular Disease Prevalence - Long-term Forecast to 2028 and 2033
January 25, 2024 04:15 ET | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Aspirin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Aspirin Industry Forecasts Surge in Demand ...
American Heart Association Logo
Updated AHA/ACCF Guidelines for Unstable Angina Include Newest Blood Thinning Drug
July 16, 2012 14:00 ET | American Heart Association
Statement Highlights: The blood-thinning drug ticagrelor is now considered equal to blood thinners clopidogrel and prasugrel for treating some patients who have a heart attack or chest...
American Heart Association Logo
Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk of Bleeding, Death
February 03, 2012 09:00 ET | American Heart Association
Study Highlights: Combining the anti-blood clot medicine clopidogrel (Plavix) with aspirin is unlikely to prevent recurrent small subcortical strokes, which are caused by blood clots deep in...